Cost-effectiveness analysis of dostarlimab plus carboplatin-paclitaxel as first-line treatment for advanced endometrial cancer
Article in Frontiers in Immunology (September 2023)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (September 2023)
Article in Pathology & Oncology Research (February 2023)
Article in Frontiers in Immunology (January 2023)